Dr. Parajuli is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
234 Goodman Street
Lab Medicine Building, Suite 110
Cincinnati, OH 45219
Education & Training
- Duke University HospitalFellowship, Cytopathology, 2016 - 2017
- University of Pennsylvania Health System Surgical PathologyFellowship, Selective Pathology, 2015 - 2016
- Temple University HospitalResidency, Pathology-Anatomic and Clinical, 2011 - 2015
- Lewis Katz School of Medicine at Temple UniversityClass of 2015
Certifications & Licensure
- WA State Medical License 2021 - 2026
- OH State Medical License 2018 - 2022
- NY State Medical License 2017 - 2019
- NC State Medical License 2016 - 2017
- PA State Medical License 2011 - 2016
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Cytopathology
Publications & Presentations
PubMed
- 48 citationsGlutaminase inhibition with telaglenastat (CB-839) improves treatment response in combination with ionizing radiation in head and neck squamous cell carcinoma models.Christina A. Wicker, Brian G. Hunt, Sunil Krishnan, Kathryn E. Aziz, Shobha Parajuli
Cancer Letters. 2021-04-01 - 24 citationsNegative Results on Thyroid Molecular Testing Decrease Rates of Surgery for Indeterminate Thyroid NodulesRachel Jug, Shobha Parajuli, Sara Ahmadi, Xiaoyin Sara Jiang
Endocrine Pathology. 2019-06-01 - 12 citationsPre-treatment absolute lymphocyte count predicts for improved survival in human papillomavirus (HPV)-driven oropharyngeal squamous cell carcinoma.Paul J Kreinbrink, J. Li, Shobha Parajuli, Trisha Wise-Draper, D.L. Choi
Oral Oncology. 2021-04-23
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: